Comment
doi: 10.1136/annrheumdis-2016-210892.
Epub 2016 Dec 23.
Disease-modifying treatment in rheumatoid arthritis: treat early and do not forget to try to taper and stop
Affiliations
- PMID: 28011451
- DOI: 10.1136/annrheumdis-2016-210892
Item in Clipboard
Comment
Disease-modifying treatment in rheumatoid arthritis: treat early and do not forget to try to taper and stop
Ann Rheum Dis.
2017 Jul.
No abstract available
Keywords: Early Rheumatoid Arthritis; Outcomes research; Treatment.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.Ann Rheum Dis. 2016 May;75(5):867-73. doi: 10.1136/annrheumdis-2014-207080. Epub 2015 May 13. Ann Rheum Dis. 2016. PMID: 25972519
-
Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al.Ann Rheum Dis. 2017 Jul;76(7):e16. doi: 10.1136/annrheumdis-2016-210887. Epub 2016 Dec 22. Ann Rheum Dis. 2017. PMID: 28007758 No abstract available.
Similar articles
-
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial.Lancet Rheumatol. 2021 Nov;3(11):e767-e777. doi: 10.1016/S2665-9913(21)00220-4. Epub 2021 Oct 1. Lancet Rheumatol. 2021. PMID: 38297524
-
Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.Curr Opin Rheumatol. 2008 May;20(3):251-6. doi: 10.1097/BOR.0b013e3282fb7caa. Curr Opin Rheumatol. 2008. PMID: 18388514 Review.
-
Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?Curr Opin Rheumatol. 2003 May;15(3):185-92. doi: 10.1097/00002281-200305000-00003. Curr Opin Rheumatol. 2003. PMID: 12707569 Review.
-
Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.Am J Med. 1988 Oct 14;85(4A):39-44. doi: 10.1016/0002-9343(88)90361-0. Am J Med. 1988. PMID: 3052055 Review.
-
Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis.Med J Aust. 2006 Feb 6;184(3):122-5. doi: 10.5694/j.1326-5377.2006.tb00150.x. Med J Aust. 2006. PMID: 16460297 Review.
Cited by
-
Identification of a Novel Serological Marker in Seronegative Rheumatoid Arthritis Using the Peptide Library Approach.Front Immunol. 2021 Oct 5;12:753400. doi: 10.3389/fimmu.2021.753400. eCollection 2021. Front Immunol. 2021. PMID: 34675934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
